Floating drug delivery systems and bioadhesive drug delivery systems are gastroretentive systems for increasing gastric residence time to obtain improved drug bioavailability. This study was to evaluate the floating and bioadhesive characteristics of Ciprofloxacin tablets formulated with Abelmoschus esculentus gum (okra gum).Okra gum was extracted and granules were prepared using the extracted Okra gum as well as sodium alginate and HPMC at concentrations of 2.5, 5 and 10 % w/w. Ciprofloxacin floating bioadhesive (CFB) tablets were evaluated for hardness, friability, in vitro buoyancy test, ex vivo bioadhesion test and drug release profiles. The floating lag time (FLT) and total floating time (TFT) for CFB tablets formulated with 10% w/w okra gum were 5.7 minutes and 8 hours respectively while the bioadhesive force was 1.324 N. Formulations of ciprofloxacin tablets containing admixtures of okra gum and sodium alginate or HPMC resulted in significant decrease (p < 0.05) in the floating lag times (≤ 3.1 minutes) and significant increase (p < 0.05) in total floating times (> 12 h). The bioadhesive force for CFB tablets containing admixtures of okra gum and sodium alginate or HPMC gave higher values in the range of 1.766 -2.207 N. The in vitro release profiles for CFB tablets formulated with okra gum alone did not show sustained release below 10 % w/w. Batches FB10 and FB11 containing admixtures showed sustained release with maximum release of 86% at maximum time of 9 h. The dissolution profiles of tablets from batches F10 and F11 compared favourably with the profile for the commercial brand of floating ciprofloxacin tablet, MF. From the study Okra gum has shown to possess good floating and bioadhesive properties and may be utilized in the formulation gastro-retentive dosage form of ciprofloxacin which can possibly be harnessed as a targeted site-specific delivery system in the eradication of Helicobacter pylori in gastric ulcer disease as well as in the treatment of Salmonella typhi induced enteric fever.
Introduction
Floating drug delivery systems (FDDS) and bioadhesive drug delivery systems (BDDS) are gastroretentive systems for increasing gastric residence time to obtain improved drug bioavailability local or systemic effects In the case of bioadhesive drug delivery system, the tablet may be forced out of the stomach mucosa wall when stomach contents are mixing around due to peristalsis 3 .
A current trend in gastroretentive drug delivery system is a combination of two approaches, so as to maximize the benefits inherent in each of them and minimize failures. Below are some possible combinations: Swellable and floating, Bioadhesive and swelling, Bioadhesive and high density, Floating and bioadhesive and Floating pulsatile systems 4 .
The combined floating -bioadhesive dosage form (FBDF) avoids disadvantages of the single or individual gastroretentive drug delivery system, decreases the frequency of drug administration, increases the desired residence of drug at the site of action, mainly in the stomach, minimizes cost of treatment as well as side effects and improves patient adherence 5, 6 . Therefore, a combined floating -bioadhesive system would surmount the disadvantages of floating and bioadhesive systems thereby improving bioavailability and ultimately improve therapeutic effect.
In recent times, researchers have harnessed this combined floating-bioadhesive system to improve drug delivery using natural gums such as cashew gum 7 , tamarind gum 8 , and guar gum 9 . Hence the aim of this study was to evaluate okra gum as a multifunctional polymer in floating-bioadhesive drug delivery.
The model drug ciprofloxacin was chosen because it is predominantly absorbed from stomach and the proximal part of the small intestine, has a short elimination half-life of 3 -4 hours, is rapidly absorbed orally, shows 60 to 70% oral bioavailability and it is administered twice or thrice daily due to its elimination half-life. This delivery system can be harnessed in the treatment of enteric fever caused by Salmonella typhi, eradication of Helicobacter pylori in peptic ulcer disease etc.
Materials and Methods

Extraction of Abelmoschus esculentus (Okra) gum
The fresh okra fruits (pods) were washed with water, chopped into smaller sizes, blended using a kitchen blender and soaked in water for 2 hour, boiled for 30 minutes and left to stand for 1 hour to allow for complete release of the mucilage into the water. The mucilage was then passed through a muslin cloth to remove the marc and then precipitated with acetone in a ratio of 1:1 (volume of acetone to volume of filtrate). The precipitated mucilage was then separated, dried in an oven at 45ºC, pulverised with mortar and pestle, passed through a 200 µm sieve and stored in an air-tight container.
Preparation of Ciprofloxacin granules
Ciprofloxacin granules were prepared using the wet granulation technique. Nine batches of granules were prepared using okra gum, sodium alginate and HPMC at concentrations of 2.5%, 5%
and 10% ᵂ/w for each of the polymers used. Two extra batches of granules were prepared using admixtures of 5% ᵂ/w okra gum with 5% ᵂ/w sodium alginate and 5% ᵂ/w okra gum with 5% ᵂ/w HPMC giving a total of eleven (11) batches (Table 2.1).
Evaluation of prepared granules
The prepared granules were evaluated for micromeritic properties such as bulk and tapped densities 10 , angle of repose 11 , Carr's index and Hausner ratio using established procedures 12 .
Bulk and tapped densities:-
A 20g quantity of granules from each batch was weighed and packed into a 50 ml graduated cylinder. The granules were carefully levelled without compacting and the unsettled apparent volume (V0) was read and recorded as the bulk volume.
Thereafter, the cylinder was tapped and the volume obtained after hundred taps (100 taps) was recorded as the final tapped volume (Vf). The process was done in triplicate and then the bulk density and tapped density in g/ml were calculated using 
Formulation of ciprofloxacin floating -bioadhesive tablets
Ciprofloxacin granules were compressed to tablets after addition of 1% ᵂ/w of talc and 1% ᵂ/w of magnesium stearate using a single punch tablet machine (Manesty Machine Ltd, B3B Liverpool, England) at 35 arbitrary units on the load scale.
The compressed tablets were collected, dedusted and stored in a labelled air tight container. The compositions of ciprofloxacin floating-bioadhesive tablets are shown in Table 1 . Total 600 600 600 600 600 600 600 600 600 600 600
FB1 -FB3 (Okra gum 2.5%, 5% and 10%), FB4 -FB6 (Sodium alginate 2.5%, 5% and 10%) FB7 -FB9 (HPMC 2.5%, 5% and 10%), FB10
(Okra gum 5% + Sodium alginate 5%) and FB11 (Okra gum 5% + HPMC 5%)
Evaluation of tablets
The compressed floating -bioadhesive tablets of ciprofloxacin were evaluated for weight uniformity, hardness and friability using standard methods for conventional tablets 13 . Tablets were also evaluated for in vitro dissolution test, in vitro buoyancy test and ex vivo bioadhesion test.
Weight uniformity
In order to carry out this test, twenty (20) tablets were randomly selected from each batch of tablets and weighed individually.
The average weights as well as percentage deviations were computed. The tablets meet the USP test if not more than 2 tablets are outside the percentage limits and if no tablets differs by more than 2 times the percentage limit.
Tablets tensile strength (Ts) Determination
The thickness (t), diameter (D) and the crushing load of each of 10 tablets selected at random were determined using Veego
Digital Tablet Hardness Test Apparatus (Veego Instruments
Corporation Mumbai -400099 India. Model NO: VDIGITAB -1.
Sr. NO: 04-1112). Mean thickness value (t) and crushing load (P) were obtained and used to calculate the tensile strength (Ts).
Tablets friability test:-
Ten (10) 
Content uniformity test
Ten tablets were randomly selected from each batch, weighed The tests were done in triplicate and mean values recorded. A plot of mean absorbance against concentrations was done to obtain the calibration curve. The same procedure was used to compute the amount of ciprofloxacin released into the dissolution medium at various time intervals.
In vitro dissolution studies
In vitro dissolution tests were performed in triplicate using dissolution tester (Erweka apparatus -type: DT, Nr: 56263, Heusenstamm, Germany), USP dissolution apparatus 1 rotating at 100 rpm in 900 ml of 0.1 N HCl at 37 ± 0.5ºC. Aliquot of dissolution medium equal to 5 ml was withdrawn at specified time intervals and same volume of fresh dissolution medium was replaced. The withdrawn media were properly diluted and the concentration of ciprofloxacin was determined using UV Spectrophotometer (PG Instrument, USA) at a wave length of 276 nm by using the regression equation from the standard calibration curve
In vitro buoyancy test
One tablet from each batch was placed in a beaker containing 900 ml of 0.1 N HCl and the time lag taken for tablet to rise to the surface and float was recorded as floating lag time (FLT), while the duration of floating on the surface without rupturing was recorded as total floating time, TFT 15, 16 .
Ex vivo Bioadhesion test
A 50 ml burette was clamped on to a retort stand and a plastic stage clamped at an angle of 30º below the burette. A freshly excised rat ileum of about 4 cm was pinned onto the stage; one tablet was weighed and placed on the exposed mucus surface.
Normal saline was allowed to flow from the burette at a rate of Angle of repose is not an intrinsic property of the powder but very much depends on the method used to form the cone (heap) of powder.
Results of ciprofloxacin tablet evaluation
Weight uniformity
All the batches complied with the weight uniformity test because for each batch, no individual tablet deviated from their respective mean values by more than ± 5%. This will help to ensure that uniformity of dosage form is achieved because the active ingredient, ciprofloxacin, forms a greater part of the tablet, unlike in cases of potent drugs administered in low doses where the excipients form the greater part of the tablet (Table 3) 
Content uniformity
All the batches complied with the test because the individual contents fell within the official range of 85 -115%. The values obtained were in the range of 95 -105% (Table 3 ). According to the European Pharmacopoeia (Ph. Eur), a batch fails to comply if more than one individual content is outside the range of 85 -115% or if one is outside the limit 75 -125% of the average content 19 .
Hardness
There is no official pharmacopoeial specification for tablet
hardness, but a tablet should not be too hard or too soft, some literatures have suggested a range of 4 -8 kg others 5 -10 kg as an acceptable hardness limit for uncoated tablets. The hardness values obtained from this study showed that only batches FB6, FB8, FB9 and MF had values above 10 kg (Table   3 ). Batch MF which is a commercial brand already in the market has a mean hardness value of 24.5 kg; this could be due to the 
Friability
All the batches had good percentage friability values except FB2 with friability value of 1.59% (Table 3) 
Tensile strength
At the compression load of 35 arbitrary units on the load scale, the tensile strength values for tablets from batch FB6 (10 % sodium alginate polymer batch) and FB8 (5% HPMC) were higher than other batches. These values were higher than those of tablets from corresponding concentrations for batches produced using okra gum (p < 0.05), as shown in Table 3 . The higher the tensile strength value, the higher the degree of plastic deformation which also leads to a greater area of contact for inter-particle bonding to form the tablets 21, 22 .
The tensile strength values for batches FB9 (okra gum / sodium alginate) and FB10 (okra gum / HPMC) was greater than batches FB1-FB3 (okra gum alone). This means that the combination of polymers led to a higher degree of plastic deformation of the granules. All the batches of ciprofloxacin showed adequate mechanical strength from the results of hardness, friability and tensile strength tests. (Table 4) , probably due to the high hardness value of 24.5 KgF (see Table 3 ). Compression force strongly affect the lag time of floating systems, tablets compressed at higher pressure were found to be less porous with high density preventing the tablets to float 24, 25 .
Floating and
The bioadhesive strengths of tablets produced with sodium alginate were greater than the corresponding concentrations of those produced with the test gum, okra gum (p < 0.05). Tablets produced with HPMC also showed slightly higher bioadhesive strengths than those of okra gum but these variations were not statistically significant (p > 0.05). Batches with the combination of okra gum and either sodium alginate or HPMC had significantly better bioadhesive strengths (p < 0.05) than those in which okra gum was used alone (Table 4) . Batch MF had good floating property but poor bioadhesive property. From the result of the floating and bioadhesive tests, it could be observed that for tablets produced with okra gum, batch FB3 had sufficiently good floating as well as bioadhesive properties (Tables 4 and Fig 1a & 1b) 
Dissolution profiles of tablets
The dissolution profiles of tablets formulated with okra gum as a release retardant revealed that okra gum was not able to sustain the release of ciprofloxacin at concentrations of 2.5% w/w (Batch FB1) and 5% w/w (Batch FB2), but at 10% w/w (Batch FB3), release was sustained for up to 8 hr (Fig 2) . The 
Drug release kinetics
The data obtained from in vitro release studies were fitted into various release models, namely; zero order, first order, Higuchi square root and Korsmeyer-Peppas model to predict or determine the kinetic and mechanism of release of ciprofloxacin. Table 5 refers to a combination of both diffusion and erosion controlled rate release (0.45 < n < 0.89). The release mechanism for all the batches of ciprofloxacin tablets was by non-Fickian diffusion (0.45 < n < 0.89) as shown in Table 5 .
Results of evaluation of drug-excipient interaction:-
The FTIR spectra of pure ciprofloxacin powder and admixture of ciprofloxacin and test gum (okra gum) are shown in Fig 6 and 7 .
The spectrum of pure ciprofloxacin showed major infra red (IR) bands in the functional group region around 2700 -3500 cm and 1600 -1800 cm -1 (which represents C=C, C=O and C=N stretches) 30 .
The spectrum of physical admixture of ciprofloxacin and okra gum showed the major bands as seen in the spectrum of ciprofloxacin but with weak intensity. The spectrum of formulated tablet (Fig 8) , showed that there were no interactions between ciprofloxacin and the excipients used in the formulation since there was no appearance of a new peak, and/or disappearance of original drug or excipient peak which would be indicative of drug -excipient interaction.respectively. While Fig 7 represents the FTIR spectrum of formulation FB3 containing 10% w/w of okra gum. Ciprofloxacin floating -bioadhesive drug delivery system can possibly be harnessed as a targeted site-specific (stomachspecific) delivery system in the eradication of Helicobacter pylori in gastric ulcer disease as well as in the treatment of Salmonella typhi induced enteric fever.
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